Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 9,002 Castle Biosciences, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 8, 2026

On Apr 6, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 9,002 Castle Biosciences, Inc. shares at US$25.03 for US$225K under a trading plan, leaving 2,780 shares. Filed Apr 8, 2026 (Form 4).

Sold
9,002 shares
Price
US$25.03
Value
US$225K
Holding after
2,780 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise6,214US$2.3927,693Direct
Apr 6, 2026Common StockSale6,214US$25.0321,479Direct
Apr 6, 2026Common StockSale1,357US$25.0348,852Indirect
Apr 6, 2026Common StockSale1,153US$25.0341,520Indirect
Apr 6, 2026Common StockSale278US$25.032,780Indirect

Source

View original at SEC

Related